Scandium-44 (<sup>44</sup>Sc) is a radioactive isotope of scandium that decays by positron emission to stable <sup>44</sup>Ca with a half-life of 4.042 hours.
<sup>44</sup>Sc can be obtained as a daughter radionuclide of long-lived <sup>44</sup>Ti (t<sub>1/2</sub> 59.1 a) from a <sup>44</sup>Ti/<sup>44</sup>Sc generator or produced by the nuclear reaction <sup>44</sup>Ca(p,n)<sup>44</sup>Sc in small cyclotrons. This isotope is of potential interest for clinical PET imaging.
<sup>44</sup>Ti with its long half-life provides a cyclotron-independent source of <sup>44</sup>Sc for decades. It is obtained by the nuclear reaction <sup>45</sup>Sc(p,2n)<sup>44</sup>Ti and transforms, through electron capture, into excited states of <sup>44</sup>Sc and emits gamma rays at 67.9 keV and 78.3 keV.
The <sup>44</sup>Ti/<sup>44</sup>Sc generator represents a secular equilibrium system with a half-life ratio between parent and daughter of about 128,000, which can be treated as virtually infinite. Consequently, half the saturation activity is generated every four hours (<sup>44</sup>Sc half-life), and identical <sup>44</sup>Sc batch activities very close to saturation may be eluted each day. One can attain >97% elution efficacy for <sup>44</sup>Sc and very low breakthrough of <5*10<sup>âÂÂ5</sup> % of <sup>44</sup>Ti.
<sup>44</sup>Ti is adsorbed onto a column filled with anion-exchange resin. <sup>44</sup>Sc is eluted with 20 mL of 0.005M H<sub>2</sub>C<sub>2</sub>O<sub>4</sub>/0.07M HCl solution. The eluate is directly post-processed on miniaturized column filled with cation-exchange resin where <sup>44</sup>Sc is quantitatively adsorbed online and successively eluted using 2âÂÂ3 mL of 0.25 M ammonium acetate buffer (pH 4.0). This <sup>44</sup>Sc solution of small volume and free of competing oxalates can be used for further labelling studies. small cyclotrons.
<sup>44</sup>Sc complexates with DOTA, a well-established bifunctional chelators conjugated to peptides or other molecular targeting vectors, its half-life of 4 h, a high positron branching, stable and non-toxic decay product and being generator-produced makes it an appropriate candidate in PETâÂÂCT diagnosis. <sup>44</sup>Sc has an almost 4-times longer half-life and higher ò<sup>+</sup> branching than commonly used <sup>68</sup>Ga, therefore it can be used for more accurate planning and dosimetric calculations being able to cover imaging periods of more than one day. A specific field might be application of diagnostic <sup>44</sup>Sc tracers for matching therapeutic analog compounds labelled with another radioisotope such as <sup>90</sup>Y, <sup>177</sup>Lu or with the ò<sup>âÂÂ</sup> emitter <sup>47</sup>Sc.
Recent studies with <sup>44</sup>Sc-DOTA-conjugated tumor targeting vectors such as octreotides, showed in vitro and in vivo stability and revealed pharmacological parameters adequate to long-term (up to one day) molecular imaging. Initial human studies with <sup>44</sup>Sc-DOTATOC PET/CT imaging of somatostatin receptor positive liver metastases in a patient at early time-points (40 min p.i.) showed comparable results to <sup>68</sup>Ga-DOTATATE (90 min. p.i.) in the same patient.